Most Popular

Healthpeak Properties Enters Oversold Territory

Healthpeak Properties Inc (NYSE: PEAK) stocks entered oversold territory on Monday, trading as low as $24.14 per share, with a Relative Strength Index (RSI) ...

Top Momentum Stocks to Consider for December 23

Valero Energy Corporation (VLO) has experienced a notable rise of 22.1% in its share price over the last three months, surpassing the S&P 500’s ...

Maximize Your Income: Boost Golar LNG Yield to 7.5% with Options Strategies

Shareholders of Golar LNG Ltd (GLNG) can enhance their income by selling a covered call option with a $50 strike price expiring in December ...

Significant Withdrawal Hits Franklin Income Focus ETF

The Franklin Income Focus ETF (Symbol: INCM) has experienced a significant outflow of approximately $67.6 million, marking a 5.9% decrease in shares outstanding week-over-week, ...

Significant Fund Inflows Observed in RECS, VOX, BMY, and NKE ETFs

The Columbia Research Enhanced Core ETF (RECS) experienced a significant inflow of approximately $656.3 million, representing a 14.3% week-over-week increase in outstanding units, rising ...

Evaluating the Sustainability of Coach’s Luxury Strategy for TPR’s Competitive Advantage in FY26

Tapestry, Inc. reported a 21% year-over-year revenue increase for its Coach brand in the first quarter of fiscal 2026, achieving a total revenue boost ...

JAAA: Monitoring Significant ETF Withdrawals

The Janus Henderson AAA CLO ETF (Symbol: JAAA) experienced a significant outflow of approximately $524.6 million, marking a 2.1% decrease in outstanding shares week ...

Market Stability Maintained as Rate-Cut Expectations Diminish Following Robust US GDP Results

On December 20, 2025, the S&P 500 Index rose by 0.06%, while the Dow Jones Industrial Average decreased by 0.07%, and the Nasdaq 100 ...

PARR Surpasses Key Technical Benchmark

In trading on Tuesday, Par Pacific Holdings Inc. (Symbol: PARR) shares fell to $35.32, entering oversold territory with a Relative Strength Index (RSI) of ...

GILD Secures Licensing Rights for Assembly Bio’s Herpes Programs

Gilead Sciences (GILD) has exercised its option to exclusively license Assembly Biosciences’ (ASMB) herpes simplex virus (HSV) helicase-primase inhibitor programs, including investigational candidates ABI-1179 ...